Cargando…
Efficacy of platinum-based chemotherapy and prognosis of patients with pancreatic cancer with homologous recombination deficiency: comparative analysis of published clinical studies
The aim of our study was to determine the effect of homologous recombination deficiency (HRD) on prognosis and efficacy of platinum-based chemotherapy in patients with pancreatic cancer (PC). We performed PubMed and Embase database queries. We included 4 studies into the meta-analysis and 16 studies...
Autores principales: | Pokataev, Ilya, Fedyanin, Mikhail, Polyanskaya, Elizaveta, Popova, Anna, Agafonova, Julia, Menshikova, Sophia, Tryakin, Alexey, Rumyantsev, Alexey, Tjulandin, Sergei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7003386/ https://www.ncbi.nlm.nih.gov/pubmed/33551067 http://dx.doi.org/10.1136/esmoopen-2019-000578 |
Ejemplares similares
-
Platinum-based chemotherapy for pancreatic cancer: impact of mutations in the homologous recombination repair and Fanconi anemia genes
por: Emelyanova, Marina, et al.
Publicado: (2022) -
Case Report: Progressive disease of BRCA2-mutant colon adenocarcinoma following talazoparib therapy
por: Polyanskaya, Elizaveta, et al.
Publicado: (2023) -
Clinical significance of molecular subtypes of gastrointestinal tract adenocarcinoma
por: Ignatova, Ekaterina Olegovna, et al.
Publicado: (2022) -
Epoetin Theta in Anaemic Cancer Patients Receiving Platinum-Based Chemotherapy: A Randomised Controlled Trial
por: Tjulandin, Sergei A, et al.
Publicado: (2010) -
Association between homologous recombination deficiency and outcomes with platinum and platinum-free chemotherapy in patients with triple-negative breast cancer
por: Chen, Yimeng, et al.
Publicado: (2023)